1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Consensus
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on BIONTECH SE
Target Price consensus revisions : last 18 months
Recommendations (Chart) BIONTECH SE
Analyst Recommendations on BIONTECH SE
05/24Goldman Sachs Adjusts BioNTech's Price Target to $206 from $255, Keeps Neutral Rating
MT
05/17UBS Adjusts BioNTech Price Target to $168 From $170, Maintains Neutral Rating
MT
05/11BIONTECH : Goldman Sachs sticks Neutral
MD
05/10Morgan Stanley Lowers BioNTech SE's Price Target to $195 From $197, Equalweight Rating Kep..
MT
05/09BIONTECH : JP Morgan reiterates its Neutral rating
MD
05/09BIONTECH : Jefferies reiterates its Neutral rating
MD
04/12HC Wainwright Adjusts BioNTech's Price Target to $298 from $339, Keeps Buy Rating Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 147,43 €
Average target price 224,49 €
Spread / Average Target 52,3%
High Price Target 331,98 €
Spread / Highest target 125%
Low Price Target 159,26 €
Spread / Lowest Target 8,03%
Consensus detail
Consensus revision (last 18 months)